These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2314611)

  • 21. [Multiple myeloma: therapeutic response to 2 modalities of chemotherapy].
    Lira P; Walker B; Grebe G
    Rev Med Chil; 1986 May; 114(5):436-40. PubMed ID: 3589221
    [No Abstract]   [Full Text] [Related]  

  • 22. [Heterogenicity of the response to chemotherapy in plasmablastic myeloma].
    Paule B; Quillard J; Bisson M; Massias P
    Nouv Rev Fr Hematol (1978); 1987; 29(6):391-6. PubMed ID: 2454453
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Multiple myeloma of the IgD-lambda type invading CNS].
    Kitamura K; Takeuchi J; Kanbe E; Oka H; Saiki M; Aikawa S; Kura Y; Hatta Y; Yamazaki T; Ito T; Sawada U; Horie T
    Rinsho Ketsueki; 2004 Oct; 45(10):1124-8. PubMed ID: 15553049
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell kinetics and therapy in multiple myeloma: an update of the M83 protocol.
    Pileri A; Barbui T; Boccadoro M; Comotti B; Dammacco F; Gallamini A; Marmont F; Neretto G; Petrucci MT; Resegotti L
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():168-9. PubMed ID: 2713554
    [No Abstract]   [Full Text] [Related]  

  • 25. [Treatment of multiple myeloma in stages II and III with melphalan, prednisone, cyclophosphamide, vincristine and BCNU (M-2 protocol)].
    Montalbán C; Sevilla F; Zapatero A; Blanco L; Sabán J; Serrano M; Serrano Ríos M
    Rev Clin Esp; 1985 May; 176(8):392-5. PubMed ID: 3839590
    [No Abstract]   [Full Text] [Related]  

  • 26. [Evaluation of the prognosis and response to therapy in multiple myeloma].
    Venturino M; Geniram A; Guarino P; Scio P; Marini U
    Recenti Prog Med; 1984 May; 75(5):451-61. PubMed ID: 6484288
    [No Abstract]   [Full Text] [Related]  

  • 27. IgD multiple myeloma--a clinical profile and outcome with chemotherapy and autologous stem cell transplantation.
    Wechalekar A; Amato D; Chen C; Keith Stewart A; Reece D
    Ann Hematol; 2005 Feb; 84(2):115-7. PubMed ID: 15503021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Combination chemotherapy with vincristine, melphalan, CCNA, cyclophosphamide, prednisone in myeloma].
    Le Loët X; Monconduit M; Menard JF; Deshayes P; Grobois B; Tanguy A; Prevost E; Piguet H
    Rev Rhum Mal Osteoartic; 1984 May; 51(5):263-7. PubMed ID: 6740189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Multiple myeloma].
    Kanoh T
    Rinsho Ketsueki; 1989 Aug; 30(8):1212-5. PubMed ID: 2601036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Polychemotherapy in multiple myeloma. The COMPA protocol].
    Vázquez-Villegas V; Delgado Lamas JL; Romero-García F; Rodríguez-Carrillo J; Medina-Ruiz F
    Rev Invest Clin; 1989; 41(4):345-50. PubMed ID: 2698501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Plasmocytic pleural effusion disclosing multiple myeloma].
    Elloumi M; Frikha M; Masmoudi H; Mseddi S; Ben Ayed M; Bouaziz M; Makni F; Souissi T
    Rev Mal Respir; 2000 Apr; 17(2):495-7. PubMed ID: 10859769
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [IgD-type multiple myeloma with confirmation of improvement in renal pathology achieved by chemotherapy].
    Otsubo H; Utsunomiya Y; Ikeda M; Kaito K; Kawamura T; Hosoya T
    Nihon Naika Gakkai Zasshi; 1998 Aug; 87(8):1560-2. PubMed ID: 9780686
    [No Abstract]   [Full Text] [Related]  

  • 33. IgD-kappa myeloma: an unusual case.
    Tharp AM; Woodruff RD; Shihabi ZK
    Ann Clin Lab Sci; 2003; 33(1):97-100. PubMed ID: 12661904
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Indications for chemotherapy in multiple myeloma].
    Heyll A; Aul C
    Dtsch Med Wochenschr; 1996 May; 121(20):675. PubMed ID: 8635404
    [No Abstract]   [Full Text] [Related]  

  • 35. Bortezomib plus melphalan and prednisone for multiple myeloma.
    Avvisati G
    N Engl J Med; 2008 Dec; 359(24):2613; author reply 2613-4. PubMed ID: 19090032
    [No Abstract]   [Full Text] [Related]  

  • 36. Multiple myeloma: the National University Hospital (NUH) experience.
    Lim HL; Teo CP; Wong K; Kuperan P; Suri R; Tan YO; Kueh YK
    Singapore Med J; 1994 Aug; 35(4):371-3. PubMed ID: 7899894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunoglobulin D multiple myeloma in our hospital--a rare occurrence.
    Tan LK; Suri R; Lim HL; Ong SK
    Singapore Med J; 2000 Oct; 41(10):500-3. PubMed ID: 11281443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term survival of stage I multiple myeloma given chemotherapy just after diagnosis or at progression of the disease: a multicentre randomized study. Cooperative Group of Study and Treatment of Multiple Myeloma.
    Riccardi A; Mora O; Tinelli C; Valentini D; Brugnatelli S; Spanedda R; De Paoli A; Barbarano L; Di Stasi M; Giordano M; Delfini C; Nicoletti G; Bergonzi C; Rinaldi E; Piccinini L; Ascari E
    Br J Cancer; 2000 Apr; 82(7):1254-60. PubMed ID: 10755397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Testicular involvement in IgD multiple myeloma].
    Kawauchi K; Ogasawara T; Yasuyama M; Ohkawa S; Aiba M
    Rinsho Ketsueki; 2001 Nov; 42(11):1128-33. PubMed ID: 11808083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MR imaging of multiple myeloma in tumour mass measurement at diagnosis and during treatment.
    Carlson K; Aström G; Nyman R; Ahlström H; Simonsson B
    Acta Radiol; 1995 Jan; 36(1):9-14. PubMed ID: 7833177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.